Ameriprise
FRO icon

Ameriprise’s Frontline FRO Stock Holding History

Ameriprise’s Portfolio FRO Stock Details FRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,211
Closed -$279K – 4110
2024
Q3 		$279K Sell
12,211
-18,636
-60% -$439K ﹤0.01% 3662
2024
Q2 		$791K Buy
30,847
+295
+1% +$7.51K ﹤0.01% 3251
2024
Q1 		$714K Buy
30,552
+1,532
+5% +$34.6K ﹤0.01% 3299
2023
Q4 		$582K Sell
29,020
-14,285
-33% -$295K ﹤0.01% 3398
2023
Q3 		$813K Buy
43,305
+19,137
+79% +$322K ﹤0.01% 3232
2023
Q2 		$351K Buy
+24,168
New +$361K ﹤0.01% 3569
2014
Q4 		– Sell
-522
Closed -$4K – 3963
2014
Q3 		$4K Buy
522
+111
+27% +$1.22K ﹤0.01% 5206
2014
Q2 		$6K Buy
411
+317
+337% +$4.83K ﹤0.01% 4883
2014
Q1 		$2K Hold
94
– – ﹤0.01% 5049
2013
Q4 		$1K Sell
94
-642
-87% -$8.82K ﹤0.01% 4986
2013
Q3 		$10K Buy
736
+67
+10% +$841 ﹤0.01% 4901
2013
Q2 		$6K Buy
+669
New +$6.63K ﹤0.01% 5067

Other funds holding FRO

F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HP
Hartree Partners New York $467M AUM 66.71% 1-Year Est. Return

Ameriprise's FRO Position: Q4 2024 in Review

Ameriprise sold out of Frontline (FRO) in Q4 2024, closing a stake of 12,211 shares — an estimated $279K sold.

Ameriprise first reported a position in FRO in Q2 2013 and held it in 12 quarters. The position peaked at $813K in Q3 2023. 172 funds tracked by Wall St. Rank hold FRO as of Q4 2024.

  • Ameriprise reported no remaining Frontline position as of Q4 2024 after selling out during the quarter.
  • Ameriprise sold 12,211 Frontline shares in Q4 2024, an estimated $279K.
  • Ameriprise first reported a position in Frontline in Q2 2013 and held it in 12 quarters.
  • Ameriprise's Frontline position peaked at $813K in Q3 2023.
  • 172 funds tracked by Wall St. Rank held Frontline as of Q4 2024.

Based on Ameriprise's 13F filing for Q4 2024, filed 14 Feb 2025.